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Abstract
Recent studies suggest that copy number polymorphisms (CNPs) may play an important role in disease susceptibility and
onset. Currently, the detection of CNPs mainly depends on microarray technology. For case-control studies, conventionally,
subjects are assigned to a specific CNP category based on the continuous quantitative measure produced by microarray
experiments, and cases and controls are then compared using a chi-square test of independence. The purpose of this work
is to specify the likelihood ratio test statistic (LRTS) for case-control sampling design based on the underlying continuous
quantitative measurement, and to assess its power and relative efficiency (as compared to the chi-square test of
independence on CNP counts). The sample size and power formulas of both methods are given. For the latter, the CNPs are
classified using the Bayesian classification rule. The LRTS is more powerful than this chi-square test for the alternatives
considered, especially alternatives in which the at-risk CNP categories have low frequencies. An example of the application
of the LRTS is given for a comparison of CNP distributions in individuals of Caucasian or Taiwanese ethnicity, where the LRTS
appears to be more powerful than the chi-square test, possibly due to misclassification of the most common CNP category
into a less common category.
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Introduction
Large-scale copy number polymorphisms (CNPs) are a recently
discovered feature of human genomic architecture [1]. As reported
by Sebat et al. [1], large-scale copy number polymorphisms
(CNPs) (about 100 kilobases and greater) contribute substantially
to genomic variation among normal humans. These authors
documented CNPs of 70 different genes within CNP intervals,
including genes involved in neurological function, regulation of
cell growth, regulation of metabolism, and several genes known to
be associated with disease. For example, investigators have
documented that copy number variation of the region encom-
passing the CCL3L1 gene [MIM 601395] is associated with HIV/
AIDS susceptibility [2] [MIM 609423]. Other investigators have
documented that copy number variation of the orthologous rat
and human FCGR3 genes [MIM 146740] is a determinant of
susceptibility to immunologically mediated glomerulonephritis
[3,4] [MIM 610665]. Additional recent publications suggest that
CNPs may play a role in cardiovascular disease [5], lipoprotein
and metabolic phenotypes [6], nervous system disorders [7], age-
related macular degeneration [8,9] [MIM 610149], autism [10],
cancer [1,11], and schizophrenia [12]. More generally, CNPs may
play an important role in disease etiology for common, complex
traits. Additionally, CNPs, like SNPs and microsatellite markers,
may have different distributions for populations with different
ethnicities [13,14].
Case-control genetic association designs can be a powerful way
to map disease susceptibilty genes, particularly for diseases with
smaller effect sizes [15,16,17,18,19]. In such designs, unrelated
cases (with the phenotype of interest) and controls (who do not
have the phenotype) are genotyped usually for thousands to
hundreds of thousands of single nucleotide polymophisms (SNPs)
across the human genome. Standard statistical analyses include the
chi-square test of independence or the linear trend test [20,21]
applied to the individual SNP genotype counts from cases and
controls. These genotypes are usually determined through use of
clustering algorithms applied to underlying quantitative measure-
ments (e.g., see [22]).
Compared to SNP genotyping technologies, procedures for
calling CNPs are less developed and less accurate [23]. Earlier
CNP studies focused on discovery [24], with copy number changes
being called using data from a single array, comparing DNA from
an individual with a reference DNA sample. Recently developed
methods classify known CNPs using array data collected from a
large group of individuals. One method classifies known CNPs
from the distribution of a univariate quantitative measure (C.
Yoon; manuscript in preparation). Such a quantitative measure is
either an average log fluorescent intensity ratio (between sample
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3475and reference DNA) over multiple probes representing the CNP,
or the log-intensity ratio of the best probe within the CNP region.
One reason for the relative difficulty of CNP classification is that
such classification is determined by relative intensity of a signal at a
probe (or probe sets). In contrast, the two alleles of a SNP have two
distinct nucleotides that can be represented by two distinct probes.
Moreover, for multi-allelic CNPs, only the total number of copies
(or categories) and not the alleles are observed for each individual.
As an example, for a CNP locus of three alleles, with 1 copy, 2
copies and 3 copies respectively and probe intensity proportional
to the number of copies, an intensity observation of 4 can be a
genotype of 2/2 copies or a genotype of 1/3 copies.
Consider the pictorial examples in Figures 1a and 1b, which are
created to represent a hypothetical CNP with a total of four different
copy number categories (labeled ‘‘1’’ through ‘‘4’’). For each
category, different subjects will have a quantitative measure following
a fixed continuous distribution, whe t h e ro rn o tt h es u b j e c ti sac a s eo r
control. The case category frequencies are then the mixing
proportions of the component distributions [25]; similarly for the
controls. In Figure 1a, the quantitative measures for CNP category i,
1#i#4 comes from a univariate normal distribution with mean i and
variance 1= 36 each. Studying the figure, we see there is clear separation
among the component normal distributions, so that classification of
individuals into categories 1,…, 4 is highlyaccurate [26].An example
where classification is more problematic is presented in Figure 1b. In
this figure, the CNP quantitative measures for subjects have normal
distributions with the same means as in Figure 1a, but with variance
J each. That is, for each univariate distribution in Figure 1b, the
variance is nine times that of the variance in Figure 1a, resulting in
greater overlap among component distributions. As suggested by
Figure 1b, when the component distributions have more overlap, the
rate of misclassifying an individual having true CNP category i as
having CNP category j?i is much higher. It has been reported that
the chi-square test of independence loses power as the misclassifica-
tion rate increases [26,27,28].
An additional concern is that the CNP category that increases
risk may occur with low frequency, as is often the situation with
Mendelian diseases [29]. In case-control association studies using
SNPs with low at-risk allele frequency, an increase in the genotype
misclassification error rates requires indefinitely large increases in
sample size to maintain constant power [30,31]. We hypothesize
that CNP classification errors may lead to underpowered studies
when the at-risk CNP category has low frequency. Challenges of
performing association studies using CNP data were recently
documented by McCarroll and Altshuler [32], who note, ‘‘To the
extent that the precise allelic state of any DNA is not well
measured, power declines.’’ We raise the question: Is there a more
(statistically) powerful method of using CNP data when testing for association
with a complex trait than the usual chi-square test of independence?
To answer this question, we propose use of the likelihood ratio
test statistic (LRTS) comparing the mixing proportions of cases and
controls estimated from the underlying quantitative measures for
CNPs. Rather than assign classifications to each individual’s CNP,
we perform a test of association on the CNP quantitative measure.
We present an analytic solution to computation of power and
sample size calculations for genetic association with CNP
quantitative measures. We then calculate the efficiency of the
chi-square test of independence using Bayesian classification
compared to the LRTS to examine which test statistic has greater
power for a wide range of trait specifications. By efficiency, we
mean the ratio of sample size requirements for the chi-square test
of independence and LRTS, respectively, for a fixed power and
type I error rate. Finally, we demonstrate the use of the LRTS for
differences in the mixing proportions of the CNP categories
between two ethnic groups for a CNP with relevance to a genetic
disease.
Methods
Notation
The following notation is used throughout this work:
Xa=A continuous random variable representing the CNP
quantitative measure; a is an index indicating control (a=1) or
case (a=2) status.
Figure 1. 1a and 1b. In this figures, we present probability density plots for statistical distributions that are mixtures of four
univariate normal distributions with equally spaced means 1, 2, 3, and 4, and a common variance. In Figure 1a, the variance of each
component distribution is 1= 36. In Figure 1b, the variance of each component distribution is J.
doi:10.1371/journal.pone.0003475.g001
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Qa~ na
n1zn2 , a~1,2, which is the proportion of controls or cases in
the total sample.
d=The number of CNP categories; the subscript i indexes the
category, 1#i#d.
f(x|hi,g)=The probability density function (pdf) of the contin-
uous random variable X=x, conditional on the CNP category.
This pdf is a function of the parameters hi and g, where g is a
parameter that is constant for all component distributions. For
example, if f is a normal pdf, then hi is the mean and g is the
variance.
p !
a~ pa1,   ,pad ðÞ =A vector of mixing proportions; here, the
values pai,1 #i#d, are the proportions of CNP category i in the a
affection status class (a=1 for controls, a=2 for cases). Under the
null hypothesis, p1i=p2i.
p0i=Q1p1i+Q2p2i. Since, under the null hypothesis, p1i=p2i, then
p1i=p2i=p0i, under the null.
qi=The CNP category frequencies in the population from
which cases and controls are drawn.
cai~
ﬃﬃﬃﬃﬃ
N
p
pai{p0i ðÞ =A parameter needed for specification of
the alternative hypothesis and hence power and sample size
calculations.
h
!
~ h1,   ,hd ðÞ =A vector of parameters for the probability
density functions f(x|hi,g). In the examples used here, hi is the
mean of the CNP category i distribution. Also, in the efficiency
calculations reported later, hi+12hi=1, i=1,…, d21. The
separation S~
hiz1{hi ﬃﬃ
g
p is the number of standard deviations
between adjacent CNP category means.
Probability density function of the CNP quantitative
measure
The probability density function of the random variable Xa is
given by ha xp !
a, h
!
,g
     
  
~
P d
i~1
paifx hi,g j ðÞ , where we assume the
number of categories d is known and equal in both cases and
controls. Given a CNP category i, the underlying pdf f(?) is the
same for cases and controls. When f(x|hi,g) is a normal
distribution, we specify that the variance (g) is equal across all
CNP categories i and affection statuses a. While these specifica-
tions are not critical for performing power and sample size
calculations, they may be advantageous when performing mixture
analyses of real data. For instance, there may be convergence
problems for the computed maximum likelihood of a univariate
normal mixture if one allows the category variances to be unequal.
Methods such as those proposed by Hathaway [33,34] may be
used when the equal variance assumption does not hold.
Likelihood function
The likelihood function under the null hypothesis is given by:
L0~ P
n1zn2
j~1
X d
i~1
p0ifx j hi,g j
  
 !  !
: ð1Þ
The likelihood function under the alternative hypothesis is given
by:
L1~ P
n1
j~1
X d
i~1
p1ifx j hi,g j
  
 !  !
P
n2
k~1
X d
i~1
p2ifx k hi,g j ðÞ
 !  !  !
: ð2Þ
Computationally, L0 and L1 are calculated by using the maximum
likelihood estimates (MLEs) of the parameters.
LRTS
In this work, we consider two test statistics: (1) the LRTS applied
directly to the CNP quantitative measures for cases and controls;
and (2) the chi-square test of independence applied to 26d tables
after the CNP quantitative measures have been classified into one
of d categories for cases and controls using a Bayesian classification
rule (see section immediately following). The LRTS (1) is defined as
LRTS~2 max
p1i,p2i,hi,g
ln L1 ðÞ { max
p0i,hi,g
ln L0 ðÞ
  
, ð3Þ
where the likelihoods are defined in equations (1) and (2).
Bayesian classification rule for univariate CNP
quantitative measures
To categorizeCNP quantitative measures into a CNP category, we
consider a classification formula based on Bayes rule [35]. Since this
approach minimizes the expected cost of misclassification, as proven
in Anderson [36], it is a well-accepted approach. An observation x is
assigned to CNP category i if and only if p0ifx hi,g j ðÞ §
max
1ƒjƒd
p0jfx hj,g
      
,w h e r ep0i=Q1p1i+Q2p2i, (defined above –
Notation). For an example with d=3 copy number categories and
a normal CNP category distribution, application of the Bayes rule
yields:
x is placed in the left-most component if x,min(c12,c13),
x is placed in the middle component if c12,x,c23,
x is placed in the right-most component if max(c13,c23),x,
where cij~
hjzhi
2 {
g
hj{hi log
p0j
p0i
  
,1 #i,j#3. In applications,
(c12,c13,c23) are estimated using the MLEs of the parameters.
Simulation studies to verify asymptotic null distribution
of chi-square test with Bayesian classification
We perform simulation studies to verify the accuracy of the
asymptotic null distribution of the chi-square test of independence
applied to CNP counts after classification using the Bayesian
classification rule (described above). We consider two settings each
of sample size and mixing proportion vectors (a total of four settings).
Our mixture model is a mixture of four univariate normal
distributions with consecutive mean distances hi+12hi=1unitapart.
Separations are fixed to be
hiz1{hi ﬃﬃ
g
p ~3. We specify sample sizes
n1(=n2)=200 or 500, and mixing proportions p !
1 ~ p !
2
  
~
0:25, 0:25, 0:25, 0:25 ðÞ or 0:1, 0:2, 0:3, 0:4 ðÞ .
Computing asymptotic power for the LRTS of the CNP
quantitative measure
The asymptotic distribution of the LRTS under the null
hypothesis follows a x2
d{1 distribution under certain conditions
[37] (referred to as ‘‘classic regularity conditions’’); and the
asymptotic power under the alternative specified hypothesis
HN : pai~p0iz
cai ﬃﬃﬃ
N
p can be calculated using the non-central chi-
square distribution x2
d{1 lLRTS ðÞ with the non-centrality parame-
ter (NCP) lLRTS given in Appendix S1.
Computing asymptotic power for chi-square test of
independence
The 26d test under an alternative hypothesis HN asymptotically
follows a non-central chi-square distribution [38]. When the
component distributions have more overlap, the misclassification
rates are much higher. If the misclassification error mechanism is
random and non-differential, the observed classification probabil-
Number Association
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* can be written in terms of a matrix of classification
probabilities e=(eij), where eij=Pr (subject’s observed genotype=i|
subject’s true genotype=j). The power for the chi-square test of
independence with misclassification errors can be calculated from
the NCP lCS [27,28,38], where
lCS~NQ1Q2
X d
i~1
p
1
1i{p
1
2i
   2
p
1
0i
, and p
1
ai~
X d
j~1
eijpaj:
Genetic model parameters for efficiency analysis
We calculate the efficiency of the chi-square test on 26d
contingency tables with respect to the LRTS on CNP quantitative
measures for two genetic models of inheritance (MOI) associated
with CNPs that have been documented as a possible MOI for
CNPs [2,39]. We first specify the disease prevalence w, the
population frequencies qi for CNP category i,1#i#d, and the
relative risks Ri of becoming affected, given that an individual has
CNP category i. We then compute the penetrances gi=Pr(affec-
ted|CNP_category=i), where we specify Ri=gi/g1, so that the
reference CNP category relative risk is 1. The reference CNP
category may be chosen arbitrarily without loss of generality. The
penetrances are given by g1~
w
P d
i~1
Riqi
, and gi=Rig1. Using Bayes
Theorem, the CNP category mixing proportions conditional on
affection status are:
p1i~Pr CNP category~i unaffected j ðÞ
~
Pr unaffected,CNP category~i ðÞ
Pr unaffected ðÞ
~
1{gi ðÞ qi
1{w
,
ð4Þ
p2i~Pr CNP category~i affected j ðÞ
~
Pr affected,CNP category~i ðÞ
Pr affected ðÞ
~
giqi
w
:
For our comparative analyses, we set d=4, q1=0.4, q2=0.35,
q3=0.2, q4=0.05, and w=0.05. In the first (Dosage) model, the
risk of becoming affected increases geometrically with increase in
CNP category. We specify R2=1.8, R3=1.8
2=3.24, and
R4=1.8
3=5.83, so that risk increases by a factor of 1.8 for each
increase in CNP category.
In the second (Extremes) model, risk of becoming affected
increases for CNP categories 1 and d and decreases for all other
categories. For this work, we specify R2=0.3, R3=0.3, and
R1=R4=1. Finally, we set the means to be equally spaced for all
components. Specifically, hi=i for comparative analyses so that
separation is given by
hiz1{hi ﬃﬃ
g
p ~ 1ﬃﬃ
g
p .
Simulation studies to verify asymptotic null and
alternative distributions of LRTS
We perform simulation studies to verify the accuracy of the
asymptotic null and alternative distributions of the LRTS. For the
null distribution simulations, we consider two settings each of
sample size and mixing proportion vectors (a total of four settings).
For the alternative distribution simulations, we consider one
setting of sample size and two different MOIs (a total of two
settings). Also, for both sets of simulations, our mixture model is a
mixture of four univariate normal distributions with consecutive
mean distances hi+12hi=1 unit apart. Separations are fixed to be
hiz1{hi ﬃﬃ
g
p ~3.
For the null distribution simulations, we specify sample sizes
n1(=n2)=200 or 500, and mixing proportions p !
1 ~ p !
2
  
~
0:25, 0:25, 0:25, 0:25 ðÞ or 0:1, 0:2, 0:3, 0:4 ðÞ . For
the alternative distribution simulations, sample sizes are n1
(=n2)=200, and mixing proportions are determined using
equations (4) with the specified parameters (including CNP
population frequencies) for the Dosage and Extremes MOIs,
given above (Methods - Genetic model parameters for efficiency
analysis).
To find the global maximum (equations (1) and (2)), we use
Expectation-Maximization algorithms (EM). A small pilot study
found that there were typically three relative maxima under the null
specification and two under the alternative. Consequently, we use
100 random starting points (RSPs) for parameter estimation under
the null distribution simulations and 50 RSPs for the estimation
under the alternative distribution simulations. EM algorithm
computations are performed using MCLUST in the R program-
ming environment[40]. ForeachRSP,the convergencetoleranceis
set at 10
25 and the maximum iteration number is set at 300.
Efficiency of the chi-square test relative to the LRTS
The efficiency of the 26d test relative to the LRTS is denoted Eff
and is the ratio Eff~ lCS
lLRTS of the NCP of the chi-square test to the
NCP of the LRTS. When the relative efficiency is less than 1, the
chi-square test requires a larger sample size to achieve the same
power as the LRTS, given that both tests have the same level of
significance. For example, if the relative efficiency of the 26d test is
0.8, the 26d test requires 100 observations to have the same power
as the LRTS using 80 observations.
Example CNP data for two ancestral populations
Since recent work documents different CNP distributions in
different ethnic populations [41,42] we apply our LRTS to test for
differences in mixing proportions of CNP categories between two
groups of individuals (Caucasian and Taiwanese) using probe ratio
data for a multi-allelic CNP probe in the FCGR3 gene on
Chromosome 1. We also apply the chi-square test of independence
to the probe ratio data after the individuals are classified into
categories using the Bayesian classification rule described above.
Oligonucleotide probes are designed as described previously [43].
To be consistent with notation used throughout this work, from
this point forward we label the Taiwanese samples as ‘‘controls’’
and the Caucasian samples as ‘‘cases’’, although individuals in this
study were not ascertained for any particular disease phenotype.
Results
Simulation studies to verify asymptotic null distribution
of chi-square test with Bayesian classification
In Table 1, we report the empirical type I error rates at the 0.975,
0.10, 0.05, 0.025, and 0.01 significance levels for each set of
parameter settings. For each simulation, these type I error rates
are the proportion of replicates for which the computed LRTS
exceeds 0.2157, 6.25, 7.81, 9.348 or 11.34, which correspond to
the 0.975, 0.10, 0.05, 0.025 and 0.01 significance level cutoffs for a
central chi-square distribution with 3 degrees of freedom (the
asymptotic null distribution for each simulation). For each
empirical type I error rate, we report the 95% confidence interval,
Number Association
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the Kolmogorov-Smirnoff (KS) goodness of fit test [44,45] to each
simulations’ set of 1000 LRTS values (i.e., sample size for KS test is
1000), and report the p-values in Table 1.
In each simulation, the target type I error rate is contained in the
95% confidence interval for the corresponding empirical type I error
rate. In addition, the smallest KS test p-value is 0.36, indicating that
we do not reject the null hypothesis that the data are drawn from a
central chi-square distribution with 3 degrees of freedom.
Computing asymptotic power for LRTS of copy number
measurement
When the alternative hypothesis HN : pai~p0iz cai ﬃﬃﬃ
N
p is true, the
NCP of the LRTS may be written in a quadratic form as:
lLRTS~NQ1Q2 p11{p21,    , p1 d{1 ðÞ {p2 d{1 ðÞ
  
J0
p11{p21
. .
.
p1 d{1 ðÞ {p2 d{1 ðÞ
0
B B B @
1
C C C A
where J0 is the (d21)6(d21) symmetric matrix specified in
Appendix S1.
Simulation studies to verify asymptotic null and
alternative distributions of LRTS
As in Table 1, in Table 2, we report the empirical type I error
rates at the 0.10, 0.05, and 0.01 significance levels for each set of
parameter settings. For each simulation, these type I error rates
are the proportion of replicates for which the computed LRTS
exceeds 6.25, 7.81, or 11.34, which correspond to the 0.10, 0.05,
and 0.01 significance level cutoffs for a central chi-square
distribution with 3 degrees of freedom (the asymptotic null
distribution for each simulation). For each empirical type I error
rate, we report the 95% confidence interval, based on 1000
replicates. As an additional confirmation, we apply the Kolmo-
gorov-Smirnoff (KS) goodness of fit test [44,45] to each
simulations’ set of 1000 LRTS values (i.e., sample size for KS
test is 1000), and report the p-values in Table 2.
In each simulation, the target type I error rate is contained in
the 95% confidence interval for the corresponding empirical type I
error rate. In addition, the smallest KS test p-value is 0.34,
indicating that we do not reject the null hypothesis that the data
are drawn from a central chi-square distribution with 3 degrees of
freedom.
In Table 3, we report the simulation power at the 10
23,1 0
24,a n d
10
25 significance levels for each set of parameter settings. For each
simulation, these powers are the proportion of replicates for which
the computed LRTS exceeds 16.27, 21.11, or 25.90, which
correspond to the 10
23,1 0
24,a n d1 0
25 cutoffs for a central chi-
square distribution with 3 degrees of freedom (the asymptotic null
distribution for each simulation). More stringent significance level
cutoffs are chosen for the power analyses since power at the 0.10,
0.05,and0.01 levelsisclose to orequal to100%fortheseparameter
specifications. As with the empirical type I error rates in Table 1, we
report the 95% confidence intervals, based on 1000 replicates each.
We also report the asymptotic power at each of the significance
levels, determined by computing the non-centrality parameter
(equation (A1)) for each set of parameter settings. As an additional
confirmation, we apply the Kolmogorov-Smirnoff (KS) goodness of
fit test [44,45] to each simulations’ set of 200 LRTS values (i.e.,
sample size for KS test is 200), and report the p-values in Table 3.
While the KS p-values are much smaller, we see that, for the
10
23 and 10
24 significance levels, the simulation power is
contained in the 95% confidence interval for each simulation.
The results of this table suggest that our simulation results are
consistent with asymptotic results for at least the 10
23 and 10
24
significance levels.
Table 1. Simulation results of the null distribution of chi-squared test.
Sample size Proportions Empirical type I error rate* KS-Test P-value
0.975 Level 0.10 Level 0.05 Level 0.025 Level 0.01 Level
200 (0.25, 0.25, 0.25, 0.25) 0.976 0.107 0.042 0.018 0.005 0.72
500 (0.25, 0.25, 0.25, 0.25) 0.971 0.092 0.047 0.025 0.007 0.78
200 (0.1, 0.2, 0.3, 0.4) 0.979 0.094 0.046 0.018 0.006 0.54
500 (0.1, 0.2, 0.3, 0.4) 0.983 0.106 0.056 0.036 0.010 0.36
Based on 1000 replications for each settings.
doi:10.1371/journal.pone.0003475.t001
Table 2. Simulation results of the null distribution of LRTS.
Sample size Proportions Empirical type I error rate* KS-Test P-value
0.975 Level 0.10 Level 0.05 Level 0.025 Level 0.01 Level
200 (0.25, 0.25, 0.25, 0.25) 0.979 0.103 0.045 0.015 0.007 0.81
500 (0.25, 0.25, 0.25, 0.25) 0.971 0.097 0.052 0.021 0.013 0.79
200 (0.1, 0.2, 0.3, 0.4) 0.977 0.106 0.046 0.020 0.005 0.34
500 (0.1, 0.2, 0.3, 0.4) 0.982 0.109 0.060 0.028 0.011 0.41
Based on 1000 replications for each settings.
doi:10.1371/journal.pone.0003475.t002
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the LRTS
Using the result for the NCP of the LRTS,
Eff~
P d
i~1
p
1
1i
{p
1
2i ðÞ
2
Q1p
1
1i
zQ2p
1
2i
P d{1
i~1
P d{1
j~1
Jij p1i{p2i ðÞ p1j{p2j ðÞ
, where
Jij~E0
fx hi,g j ðÞ {fx hd,g j ðÞ ðÞ fx hj,g j ðÞ {fx hd,g j ðÞ ðÞ
P d
k~1
Q1p1kzQ2p2k ðÞ fx hk,g j ðÞ
   2
0
B B B @
1
C C C A
. Figure 2 contains
the relative efficiency of the 264 chi-square test with Bayesian rule
classification with respect to the LRTS for the Extremes and Dosage
models against the separation between successive category means.
In all models, the relative efficiency is less than 1; that is, the LRTS is
more powerful. When the separation is 5 standard deviations or
greater, both tests have essentially the same power. The relative
efficiency steadily declines as the separation between category
means decreases, with less efficiency for the Extremes model.
Example CNP data for two populations
Results for the LRTS applied to P4077 probe ratio data for the
Caucasian and Taiwanese samples are presented in Table 4.
Figure 3 contains the histograms of each group’s probe ratio data,
as well as of the combined groups (Caucasians and Taiwanese).
There are an estimated three CNP categories, and the LRTS p-
value for the P4077 probe is 0.014. In comparison, the chi-square
test of independence p-value based on the asymptotic null
distribution for the P4077 probe data with classification by the
Bayesian rule is 0.03. The p-value based on Fisher’s Exact Test is
0.0175. The numbers of Caucasian and Taiwanese individuals in
CNP categories 1, 2, and 3 are: 229, 31, and 1; and 67, 20, and 1,
respectively, as determined by the Bayesian classification rule.
Additionally, we report the estimated classification rates as follows:
e~
0:963 0:037 0:000
0:335 0:663 0:002
0:000 0:087 0:913
0
B @
1
C A,
where eij=Pr(reported CNP classification=j|true CNP classification=i).
The LRTS method provides a slightly more significant p-value.
When we use the estimated misclassification parameters in the
matrix e along with the estimated mixing proportions under the
alternative hypothesis (Table 4) in the Power for Association With
Error (PAWE) webtool, the power at the 5% significance level for
the sample sizes specified in our example is 98% with error-free
data, and is 76% with error rates given in e, a power loss of 22%.
From the perspective of power loss, Kang et al. [30,31] showed
that misclassification of the most common category to any other
category is the most costly; here, the estimated error rate of 3.7%
in classification CNP category ‘‘1’’ as category ‘‘2’’ results in the
greatest power loss. Other investigators have previously docu-
mented that the chi-square test of independence and the linear
trend test lose power under such misclassification when data are
genotypes or multi-locus haplotypes [30,31,46,47].
Additionally, if we compute the separation values
hiz1{hi ﬃﬃ
g
p , i=1,
2, using the estimated parameters from Table 3, we see that
separation between categories 1 and 2 is 1:42{1:056 ﬃﬃﬃﬃﬃﬃ
0:03
p ~2:09, and
separation between categories 2 and 3 is 2:18{1:42 ﬃﬃﬃﬃﬃﬃ
0:03
p ~4:38. That is,
Table 3. Simulation results for LRTS under alternative distributions.
MOI
Method to calculate
power Simulation Power* KS-Test P-value
10
23 Level 10
24 Level 10
25 Level
Dosage Simulation 0.958 (0.946, 0.970) 0.866 (0.845, 0887) 0.735 (0.708, 0.762) 0.01
Asymptotic 0.949 0.856 0.712
Extremes Simulation 0.950 (0.936, 0.964) 0.857 (0.835, 0.879) 0.738 (0.711, 0.765) 0.07
Asymptotic 0.946 0.848 0.700
Legend for Table 2. Based on 1000 replications and 200 sample size per case/control group.
*95% approximate confidence intervals for simulated power are given in parentheses.
Here, we present simulated and asymptotic power for the LRTS when the alternative hypothesis that mixing proportions are different in each of two groups is true. The
mixing proportions are computed using equations (4) for the Dosage and Extremes models, where CNP population frequencies are as specified above (Methods -
Genetic model parameters for efficiency analysis). For the Dosage model, the relative risks are: R2=1.8, R3=1.8
2=3.64, R4=1.8
3=5.83. For the Extremes model, the
relative risks are: R1=1,R2=0.3, R3=0.3, R4=1. Asymptotic power is computed using the non-centrality parameter documented in equation (A1). The column ‘‘KS-Test
P-value’’ refers to the p-value computed using the Kolmogoroff-Smirnoff goodness of fit test, as implemented in R programming environment.
doi:10.1371/journal.pone.0003475.t003
Figure 2. Here we present the relative efficiency Eff (defined in
Methods) of the chi-square test of independence in relation to
the LRTS as a function of separation ( 1ﬃﬃ
g
p ) between the four
component distributions that comprise the mixture distribution.
All information regarding parameter specification for the Dosage and
Extremes models for which relative efficiencies are calculated is
presented in the Methods section (Genetic model parameters for
efficiency analysis).
doi:10.1371/journal.pone.0003475.g002
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only 2.09. Our results of the relative efficiency studies in Figure 2
also suggest that, for such separation, the chi-square test with
Bayesian classification is a less powerful procedure than the LRTS.
While one cannot use parameters estimated from data collected
to calculate actual power, we present these calculations as
indications of the source of the greater power of the LRTS due
to the relatively high misclassification rates that are consistent with
the estimated parameters.
Discussion
We have derived the non-centrality parameter for the LRTS of
the mixture proportions applied to the CNP quantitative
measurements. The relative efficiency of the 264 chi-square test
is less than 1 for the example disease MOIs considered here, with
greater decreases as the separation between category-means
decreases. That is, for the models considered, the LRTS is more
powerful than the chi-square test. In the example, power may have
been lost for the chi-square test because of relatively high
estimated misclassification rate from the most common category
to the second most common category. The chi-square test of
independence can lose substantial power under such misclassifi-
cation [30,31,47].
A key advantage of the LRTS is that it can be computed on any
CNP data, whether or not that data can be categorized. While the
example presented (Table 4 and Figure 3) used only a single CNP
Table 4. Parameter estimation with 3 component normal
mixtures for probe P4077 ratio data.
Hypothesis Estimated parameters CNP Category
i=1 i=2 i=3
Null (H0) Mixing proportions 0.815 0.179 0.006
Means (hi) 1.062 1.446 2.191
Alternative
(HN)
Mixing proportions for Taiwanese (p1i) 0.626 0.362 0.011
Mixing proportions for Caucasians (p2i) 0.843 0.152 0.005
Means (hi) 1.056 1.420 2.180
Legend for Table 4. Data are determined for 261 individuals of Caucasian
ethnicity and 88 individuals of Taiwanese ethnicity. The estimated variance (g)
under both the null and alternative hypotheses is 0.03.
doi:10.1371/journal.pone.0003475.t004
Figure 3. In these figures, we provide histograms of P4077 probe ratio data for Taiwanese, Caucasian and Combined (Taiwanese
and Caucasian) samples. We also provide a fitted probability density function line for each data set. These graphs were created using the R
programming environment. The horizontal axis labeled ‘‘MEASUREMENT’’ refers to each individual’s probe ratio data value (after log transform) for
the P4077 probe.
doi:10.1371/journal.pone.0003475.g003
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analyzed simultaneously through specification of a multivariate
pdf. The formal statistical analysis is the same, in that the LRTS is
calculated as shown in Equation (3). Additionally, extensions of a
multivariate procedure can incorporate more complex modeling
of the mixture mechanism, for example, including a Hidden
Markov Model approach.
The results indicated in Table 1 and Figure 2, namely that non-
differential misclassification errors do not result in a change in the
type I error rate and that there is power loss for the chi-square test
of association, are consistent with numerous publications on the
subject of non-differential genotyping error. Pompanon et al. [48]
and Gordon and Finch [49,50] provide reviews of the literature.
As an alternative analysis, one might consider a logistic
regression model with case/control status as the dependent
variable and CNP quantitative measure as the independent
variable. One potential advantage of this method is that
determination of optimal estimates is less computationally
intensive than the LRTS procedure documented in this work.
Another potential advantage of logistic regression is that it allows
for the possible inclusion of covariates. In this work we focus on
the LRTS to avoid specification of a mathematical model of
association. That is, the LRTS presented here only tests whether
mixing proportions are different in two groups. There are mixture
models that examine whether covariates are associated with CNP
category membership [51,52]. A natural next step to extend our
work is to allow the inclusion of covariates. The LRTS is similar in
spirit to the commonly used chi-square test of independence for
genotype data on cases and controls. That statistic similarly tests
for differences in allele or genotype frequencies among different
categories (e.g., cases and controls). We further note that there is
literature on power and sample size for logistic regression [53,54].
While robustness of logistic regression procedures when the
independent variable is drawn from a single univariate normal
distribution is well documented (e.g., see [55]), the extension to
logistic regression procedures when the independent variable is
drawn from a mixture of distributions, as is the situation with
CNPs, needs further investigation.
The recent work documenting differences in CNP distributions
for different ethnic populations is consistent with the frequently
replicated results that there are different allele and genotype
frequency distributions in different ethnic populations [13,56]. Yu
et al. [57] confirmed CNP values with ‘‘gold-standard’’ sequencing
data. It is a limitation of our example that our estimated CNP
classifications are not confirmed with sequencing data. Recent
methodological research has documented several benefits of
having standard and gold-standard measurements simultaneously
on a subset of individuals [58,59,60]. Such sampling has been
referred to as double-sampling [61,62].
An additional limitation in the data analysis of our example is
our assumption of equal variances among the component
distributions. While this assumption appeared to be true for this
example, it will not hold in general. In that event, methods such as
those proposed by Hathaway [33,34] may be used.
The power and sample size calculations presented here are
based on asymptotic theory; that is, our results should hold when
sample sizes are sufficiently large. When sample sizes are smaller,
one can use simulation methods to estimate power. Of course, p-
values should be based on permutation tests in such instances.
Web Resources
Online Mendelian Inheritance in Man (http://www.ncbi.nlm.
nih.gov/Omim)
Power for Association With Error (http://linkage.rockefeller.
edu/pawe/)
Supporting Information
Appendix S1
Found at: doi:10.1371/journal.pone.0003475.s001 (0.02 MB
PDF)
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